GENB
Generate Biomedicines, Inc.
13.70$
-0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Generate Biomedicines, Inc. (GENB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -58 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| -53 | -49 | -80 | -58 | |
| 3.4 | 3.3 | 3.3 | 3.2 | |
| 4.7 | 5.5 | 6.4 | 8.2 | |
| -17 | -1.4 | -31 | -4.5 | |
| 0.8 | 0.2 | 3.8 | 0.9 | |
| – | – | -252 | 33 | |
| -2.6 | -2.4 | -1.1 | -1.0 | |
| 21 | -0.3 | 371 | -0.6 | |
| 43 | -66 | 161 | -25 | |
| -54 | -49 | -84 | -59 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.